BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 33252482)

  • 1. Optimizing respondent-driven sampling to find undiagnosed HIV-infected people who inject drugs.
    McFall AM; Lau B; Latkin C; Srikrishnan AK; Anand S; Vasudevan CK; Mehta SH; Solomon SS
    AIDS; 2021 Mar; 35(3):485-494. PubMed ID: 33252482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Respondent-driven sampling is more efficient than facility-based strategies at identifying undiagnosed people who inject drugs living with HIV in India.
    McFall AM; Solomon SS; Lau B; Latkin C; Srikrishnan AK; Anand S; Vasudevan CK; Kumar MS; Lucas GM; H Mehta S
    Drug Alcohol Depend; 2023 Aug; 249():110834. PubMed ID: 37352733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respondent-driven sampling for identification of HIV- and HCV-infected people who inject drugs and men who have sex with men in India: A cross-sectional, community-based analysis.
    Solomon SS; McFall AM; Lucas GM; Srikrishnan AK; Kumar MS; Anand S; Quinn TC; Celentano DD; Mehta SH
    PLoS Med; 2017 Nov; 14(11):e1002460. PubMed ID: 29182638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integration of a geospatially targeted community-based testing approach with respondent-driven sampling to identify people who inject drugs living with HIV and HCV in Patti and Gorakhpur, India.
    Loeb TA; McFall AM; Srikrishnan AK; Anand S; Vasudevan CK; Mehta SH; Solomon SS
    Drug Alcohol Depend; 2023 Jun; 247():109874. PubMed ID: 37087926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using large-scale respondent driven sampling to monitor the end of an HIV epidemic among persons who inject drugs in Hai Phong, Viet Nam.
    Des Jarlais DC; Arasteh K; Huong DT; Oanh KTH; Feelemyer JP; Khue PM; Giang HT; Thanh NTT; Vinh VH; Le SM; Vallo R; Quillet C; Rapoud D; Michel L; Laureillard D; Moles JP; Nagot N;
    PLoS One; 2021; 16(11):e0259983. PubMed ID: 34793523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14).
    Wenz B; Nielsen S; Gassowski M; Santos-Hövener C; Cai W; Ross RS; Bock CT; Ratsch BA; Kücherer C; Bannert N; Bremer V; Hamouda O; Marcus U; Zimmermann R;
    BMC Public Health; 2016 Sep; 16(1):927. PubMed ID: 27595567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the number of people who inject drugs using repeated respondent-driven sampling (RDS) in a community-based program: implications for the burden of hepatitis C and HIV infections and harm reduction coverage.
    Roussos S; Paraskevis D; Malliori M; Hatzakis A; Sypsa V
    AIDS Behav; 2023 Feb; 27(2):424-430. PubMed ID: 35947234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C bio-behavioural surveys in people who inject drugs-a systematic review of sensitivity to the theoretical assumptions of respondent driven sampling.
    Buchanan R; Khakoo SI; Coad J; Grellier L; Parkes J
    Harm Reduct J; 2017 Jul; 14(1):44. PubMed ID: 28697760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychosocial Barriers to Viral Suppression in a Community-based Sample of Human Immunodeficiency Virus-infected Men Who Have Sex With Men and People Who Inject Drugs in India.
    Prabhu S; McFall AM; Mehta SH; Srikrishnan AK; Kumar MS; Anand S; Shanmugam S; Celentano DD; Lucas GM; Solomon SS
    Clin Infect Dis; 2020 Jan; 70(2):304-313. PubMed ID: 30840989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Social network methods for HIV case-finding among people who inject drugs in Tajikistan.
    Kan M; Garfinkel DB; Samoylova O; Gray RP; Little KM
    J Int AIDS Soc; 2018 Jul; 21 Suppl 5(Suppl Suppl 5):e25139. PubMed ID: 30033684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions.
    Des Jarlais D; Duong HT; Pham Minh K; Khuat OH; Nham TT; Arasteh K; Feelemyer J; Heckathorn DD; Peries M; Moles JP; Laureillard D; Nagot N;
    AIDS Care; 2016 Oct; 28(10):1312-5. PubMed ID: 27178119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risky injection practices and HCV awareness in Chiang Mai Province, Thailand: a respondent-driven sampling study of people who inject drugs.
    Prouté M; Le Coeur S; Tiv MH; Dub T; Jongpaijitsakul P; Ratnamhin A; Angkurawaranon C; Aramrattana A; Lallemant M
    BMC Public Health; 2020 Sep; 20(1):1450. PubMed ID: 32972359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid situational assessment of people who inject drugs (PWID) in Nairobi and coastal regions of Kenya: a respondent driven sampling survey.
    Oguya FO; Kenya PR; Ongecha F; Mureithi P; Musyoka H; Muraguri N; Mundia B; Angira C; Shose M; Basheeb TA; Mohamed AA; Oyore JP; Ochieng OG; Dida GO; Abdalla S; Abdool R
    BMC Public Health; 2021 Aug; 21(1):1549. PubMed ID: 34391389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of HIV and hepatitis C infection among women who inject drugs in Northeast India: a respondent-driven sampling study.
    McFall AM; Solomon SS; Lucas GM; Celentano DD; Srikrishnan AK; Kumar MS; Mehta SH
    Addiction; 2017 Aug; 112(8):1480-1487. PubMed ID: 28317210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Employing Respondent Driven Sampling (RDS) to recruit people who inject drugs (PWID) and other hard-to-reach populations during COVID-19: Lessons learned.
    Abadie R; Habecker P; Carrasco KG; Chiou KS; Fernando S; Bennett SJ; Valentin-Acevedo A; Dombrowski K; West JT; Wood C
    Front Psychiatry; 2022; 13():990055. PubMed ID: 36262631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique.
    Semá Baltazar C; Horth R; Boothe M; Sathane I; Young P; Chitsondzo Langa D; Condula M; Ricardo H; Dengo Baloi L; Cummings B; Schaad N; Gouveia L; Teodoro E; Raymond HF
    BMC Infect Dis; 2019 Dec; 19(1):1022. PubMed ID: 31791273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV and hepatitis C prevalence, and related risk behaviours among people who inject drugs in three cities in Croatia: Findings from respondent-driven sampling surveys.
    Handanagic S; Bozicevic I; Civljak M; Dominkovic Z; Sevic S; Barbaric J; Nemeth Blazic T; Dakovic Rode O; Begovac J
    Int J Drug Policy; 2016 Jun; 32():57-63. PubMed ID: 27160504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diverse HIV epidemics among people who inject drugs in Thailand: evidence from respondent-driven sampling surveys in Bangkok and Chiang Mai.
    Prybylski D; Manopaiboon C; Visavakum P; Yongvanitjit K; Aramrattana A; Manomaipiboon P; Tanpradech S; Suksripanich O; Pattanasin S; Wolfe M; Whitehead SJ
    Drug Alcohol Depend; 2015 Mar; 148():126-35. PubMed ID: 25640153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The complex interplay of social networks, geography and HIV risk among Malaysian Drug Injectors: Results from respondent-driven sampling.
    Zelenev A; Long E; Bazazi AR; Kamarulzaman A; Altice FL
    Int J Drug Policy; 2016 Nov; 37():98-106. PubMed ID: 27639995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of HIV/Hepatitis C Virus Co-Infection and Injection Risk Correlations in People Who Inject Drugs in Colombia: A Cross-Sectional Study Using Respondent Driven Sampling.
    Toro-Tobón D; Berbesi-Fernández D
    Subst Use Misuse; 2020; 55(3):414-423. PubMed ID: 31691646
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.